Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANVS Annovis Bio, Inc.

未开盘 11-18 16:00:00 EST

6.82

-0.02

-0.29%

盘后6.74

-0.08-1.17%

19:34 EST

最高6.97	最低6.71	成交量9.87万
今开6.93	昨收6.84	日振幅3.80%
总市值9,410万	流通市值7,490万	总股本1,380万
成交额67.35万	换手率0.90%	流通股本1,098万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":6.82,"timestamp":1731963600000,"preClose":6.84,"halted":0,"volume":98717,"hourTrading":{"tag":"盘后","latestPrice":6.74,"preClose":6.82,"latestTime":"19:34 EST","volume":1516,"amount":10226.2,"timestamp":1731976454362},"delay":0,"floatShares":10982300,"shares":13797242,"eps":-3.972968,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.02,"latestTime":"11-18 16:00:00 EST","open":6.93,"high":6.97,"low":6.71,"amount":673450.6316610001,"amplitude":0.038012,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.972968,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1580274000000,"adjPreClose":6.84,"preHourTrading":{"tag":"盘前","latestPrice":6.92,"preClose":6.84,"latestTime":"08:16 EST","volume":1570,"amount":11011.420609,"timestamp":1731935805006},"postHourTrading":{"tag":"盘后","latestPrice":6.74,"preClose":6.82,"latestTime":"19:34 EST","volume":1516,"amount":10226.2,"timestamp":1731976454362},"volumeRatio":0.343346,"impliedVol":0.702,"impliedVolPercentile":0.0126},"requestUrl":"/m/hq/s/ANVS/tweets","defaultTab":"tweets","newsList":[{"id":"2483338860","title":"Annovis Bio, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483338860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483338860?lang=zh_cn&edition=full","pubTime":"2024-11-14 23:41","pubTimestamp":1731598872,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日23时41分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.26%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234112abc17fee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114234112abc17fee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2483833402","title":"Annovis Bio, Inc.2024财年第三财季实现净利润-12.64百万美元，同比增加14.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833402?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:00","pubTimestamp":1731513630,"startTime":"0","endTime":"0","summary":"11月14日，Annovis Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.64百万美元，同比增加14.13%；其中营业收入为0.00美元，每股基本收益为-0.97美元。从资产负债表来看，Annovis Bio, Inc.总负债7.30百万美元，其中短期债务0.00美元，资产负债比为1.97，流动比率为2.67。机构评级：截至2024年11月14日，当前有6家机构对Annovis Bio, Inc.目标价做出预测，其中目标均价为40.17美元，其中最低目标价为21.00美元，最高目标价为72.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000043a2348646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114000043a2348646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS"],"gpt_icon":0},{"id":"2482894738","title":"Annovis Bio, Inc.盘中异动 快速跳水5.02%报7.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482894738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482894738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335702,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.02%。截至发稿，该股报7.75美元/股，成交量6.409万股，换手率0.49%，振幅3.85%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223503971a5b1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223503971a5b1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2482807447","title":"安诺维斯生物公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482807447","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482807447?lang=zh_cn&edition=full","pubTime":"2024-11-09 20:26","pubTimestamp":1731155187,"startTime":"0","endTime":"0","summary":"   * Annovis Bio Inc   报告，截至9月30日的季度调整后每股亏损97美分，高于去年同期的每股收益1.63美元。六位分析师对该季度的平均预期是每股亏损 53 美分。华尔街预期为每股-65美分至-38美分。* Annovis Bio Inc 公布的本季度每股收益为亏损 97 美分。* Annovis Bio Inc 本季度股价上涨了 6.8%，今年迄今为止亏损了 54.0%。华尔街对 Annovis Bio Inc 的 12 个月目标价中位数为 26.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"安诺维斯生物公司公布截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS"],"gpt_icon":0},{"id":"2481100869","title":"Annovis Bio, Inc.盘中异动 早盘大幅下挫5.62%报8.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481100869?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:12","pubTimestamp":1731078757,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时12分，Annovis Bio, Inc.股票出现波动，股价急速下挫5.62%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231237971a565d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231237971a565d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2480580071","title":"Annovis Bio Inc   预计每股亏损53美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580071","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580071?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:48","pubTimestamp":1730735304,"startTime":"0","endTime":"0","summary":"   * Annovis Bio Inc    预计在11月6日公布截至0001年1月1日的业绩时，季度收入将没有变化(预计)。*    * LSEG 的分析师平均预计 Annovis Bio Inc 每股亏损 53 美分。* 在过去三个月中，分析师的平均盈利预期下降了约 26.1%。* 华尔街对 Annovis Bio Inc 的 12 个月目标价中位数为 26.00 美元，高于其最新收盘价 9.09 美元。11月4日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Annovis Bio Inc   预计每股亏损53美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANVS"],"gpt_icon":0},{"id":"2480059004","title":"Annovis Bio, Inc.盘中异动 股价大跌5.55%报9.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480059004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480059004?lang=zh_cn&edition=full","pubTime":"2024-11-01 01:08","pubTimestamp":1730394480,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日01时08分，Annovis Bio, Inc.股票出现异动，股价快速跳水5.55%。截至发稿，该股报9.02美元/股，成交量18.4844万股，换手率1.42%，振幅4.61%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为3.56%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110101080098e3fc68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110101080098e3fc68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2478048441","title":"Annovis Bio, Inc.盘中异动 早盘股价大涨5.57%报10.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478048441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478048441?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:12","pubTimestamp":1730124776,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时12分，Annovis Bio, Inc.股票出现异动，股价快速上涨5.57%。截至发稿，该股报10.42美元/股，成交量9.0964万股，换手率0.70%，振幅6.58%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822125698e3ed6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822125698e3ed6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2478241935","title":"Annovis Bio, Inc.盘中异动 早盘快速上涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478241935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478241935?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:43","pubTimestamp":1729863817,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时43分，Annovis Bio, Inc.股票出现异动，股价急速上涨5.40%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521433798e3e807&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521433798e3e807&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2477455156","title":"Annovis Bio, Inc.盘中异动 股价大跌5.09%报9.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477455156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477455156?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:13","pubTimestamp":1729703584,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时13分，Annovis Bio, Inc.股票出现波动，股价快速下跌5.09%。截至发稿，该股报9.14美元/股，成交量8.3381万股，换手率0.64%，振幅4.98%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024011305971a1dbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024011305971a1dbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2477486277","title":"Annovis Bio, Inc.盘中异动 股价大涨5.10%报9.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477486277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477486277?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:12","pubTimestamp":1729523531,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时12分，Annovis Bio, Inc.股票出现异动，股价急速上涨5.10%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5587.14%、2982.07%、1250.64%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021231211971a1686&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021231211971a1686&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2476617120","title":"Annovis Bio, Inc.盘中异动 快速下跌5.47%报8.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476617120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476617120?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:36","pubTimestamp":1729172176,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时36分，Annovis Bio, Inc.股票出现波动，股价急速下跌5.47%。截至发稿，该股报8.64美元/股，成交量4.3953万股，换手率0.34%，振幅2.57%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213616a1e1686f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017213616a1e1686f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2475123219","title":"Annovis Bio, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475123219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475123219?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:10","pubTimestamp":1729091407,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时10分，Annovis Bio, Inc.股票出现异动，股价大幅上涨5.26%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016231007a1e12270&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016231007a1e12270&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2475601396","title":"Annovis Bio, Inc.盘中异动 早盘快速下挫5.17%报7.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475601396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475601396?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:52","pubTimestamp":1728917531,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时52分，Annovis Bio, Inc.股票出现异动，股价急速下跌5.17%。截至发稿，该股报7.52美元/股，成交量12.4135万股，换手率0.95%，振幅5.74%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014225212971a0228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014225212971a0228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2472966169","title":"Annovis Bio, Inc.盘中异动 早盘快速拉升5.05%报8.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472966169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472966169?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:10","pubTimestamp":1728054636,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时10分，Annovis Bio, Inc.股票出现波动，股价快速拉升5.05%。截至发稿，该股报8.43美元/股，成交量5.7999万股，换手率0.44%，振幅5.24%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100423103698e3aa0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100423103698e3aa0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2472506243","title":"Annovis Bio, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472506243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472506243?lang=zh_cn&edition=full","pubTime":"2024-10-03 03:57","pubTimestamp":1727899025,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日03时57分，Annovis Bio, Inc.股票出现异动，股价快速拉升5.02%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410030357069719e05f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410030357069719e05f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2469145481","title":"Annovis Bio, Inc.盘中异动 早盘股价大跌5.19%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469145481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469145481?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:06","pubTimestamp":1727103980,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时06分，Annovis Bio, Inc.股票出现波动，股价快速下挫5.19%。截至发稿，该股报8.03美元/股，成交量5.4114万股，换手率0.41%，振幅5.69%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.11%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092323062098e3877b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2468509571","title":"Annovis Bio, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468509571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468509571?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:13","pubTimestamp":1726758809,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时13分，Annovis Bio, Inc.股票出现波动，股价大幅拉升5.14%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.56%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192313299719be19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192313299719be19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0},{"id":"2460063893","title":"Annovis Bio, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460063893","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460063893?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:41","pubTimestamp":1724092861,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时41分，Annovis Bio, Inc.股票出现异动，股价快速上涨5.02%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002410197199308&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002410197199308&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANVS"],"gpt_icon":0},{"id":"2459204427","title":"Annovis Bio, Inc.盘中异动 早盘股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459204427","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459204427?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:33","pubTimestamp":1723728821,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时33分，Annovis Bio, Inc.股票出现波动，股价快速拉升6.31%。截至发稿，该股报8.25美元/股，成交量1.4338万股，换手率0.13%，振幅2.13%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213341959ba0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213341959ba0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANVS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":-0.1085},{"period":"1month","weight":-0.2595},{"period":"3month","weight":-0.2354},{"period":"6month","weight":-0.1085},{"period":"1year","weight":0.1236},{"period":"ytd","weight":-0.6353}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annovis Bio, Inc.于2008年4月29日根据特拉华州法律注册成立。Annovis是一家临床阶段制药公司，专注于开发和商业化用于治疗帕金森氏症（“PD”）和阿尔茨海默氏症（“AD”）疾病以及其他神经退行性疾病的创新药物。该公司的先导化合物ANVS-401是一种神经化学神经缺陷疗法，可抑制神经变性并抑制神经毒性蛋白质转化为成人和正常化的轴突囊泡转运。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001878},{"month":2,"riseRate":0.4,"avgChangeRate":0.208855},{"month":3,"riseRate":0.4,"avgChangeRate":-0.008916},{"month":4,"riseRate":0.2,"avgChangeRate":-0.160489},{"month":5,"riseRate":0.6,"avgChangeRate":0.247553},{"month":6,"riseRate":0.6,"avgChangeRate":0.216567},{"month":7,"riseRate":0.6,"avgChangeRate":0.066217},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05366},{"month":9,"riseRate":0.4,"avgChangeRate":-0.049402},{"month":10,"riseRate":0.2,"avgChangeRate":-0.090551},{"month":11,"riseRate":0.6,"avgChangeRate":0.038532},{"month":12,"riseRate":0.5,"avgChangeRate":0.329002}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}